This #WorldHealthWorkerWeek, we honour the people who keep health systems running. 💙 Take neonatal nurses in our #NeoIPC project: supporting families, protecting tiny lives, all with precision and care. Imagine doing that without proper support. Strong health systems need strong health workers.

A step forward in paediatric HIV research! #ENABLE brings together 21 partners across Africa, Europe & the US to test whether bNAbs can improve viral control in infants. Penta leads the Ethics & Regulatory work, ensuring the trial meets the highest standards. 👉 penta-id.org/news/enable-...

Passionate about adolescent health? Working in #HIV or #SRHR? The Adol & HIV Workshop 2026 is coming to Bangkok! 📣 Call for (Research) Abstracts Deadline: 5 June Info: academicmedicaleducation.com/programs/10t... Join us in shaping the future of adolescent health! @academicmededu.bsky.social

Last week, at the #SNIP-AFRICA General Assembly in Accra 🇬🇭, we explored how can we improve management neonatal sepsis in Africa. Through research, stakeholder engagement & training activities, this project is making real strides toward better care for newborns in this setting. www.snip-africa.org

🧵1/3 The SUPPORT project that has officially recruited 100 children into the SUPPORT 1 clinical study! For hospitalised children living with HIV, the greatest risk isn't always the hospital stay, it’s the weeks after they return home.

Today is #InternationalWomen'sDay & we stand with the theme: Rights. Justice. Action. Watch to find out what defines the women of the Penta ID Network & their vital role in helping us realise our vision where the health needs of pregnant people, infants, children & adolescents are prioritised!

📌 How do #IPC practices vary across European NICUs? Join the #NeoIPC/#UENPS webinar “Neonatal Infection Prevention in Europe: Findings from the NeoIPC-UENPS Survey” 🗓️ 5 March | 13:00–14:00 CET Discover key insights drawing from 200 responses. Register 👉 www.mcascientificevents.eu/neobestpract...

@bsky.app Why do some children and pregnant women not get vaccinated? Hint: It’s not a lack of trust in science. Helen Skirrow, the recipient of the 2026 BFA Young Researcher Award, shows how sharing power with communities drives real vaccine uptake in the UK. Congratulations, Helen.

🧵1/3 On #ZeroDiscriminationDay, we are following the global lead to put People First. 🦋 At Penta, we believe that language is the foundation of dignity. This isn't about being politically correct, it’s about ensuring that a medical condition never overshadows a child’s identity.

Catch Anna Turkova & Simon Drysdale on Feb 19 (13:20-13:50) at the RSVVW’26 conference to discuss the PIPELINE-RSV trial. Learn how PIPELINE aims to use adaptive trials to improve #RSV preparedness for pregnant people and infants across Europe. More 👉 https://resvinet.org/conferences/rsvvw26/

🧵 📢 NEWS: Kenya joins @gardp.bsky.social NeoSep1 Part 2 trial on #NeonatalSepsis. The trial has started enrolling newborn babies with #sepsis at Kilifi County Hospital (Kilifi) Coast General Teaching & Referral Hospital (Mombasa) and Mbagathi Hospital (Nairobi). 🇰🇪

Today is the #InternationalDayOfWomenAndGirlsInScience and we asked the women within the Penta ID Network to share a message for girls who are interested in STEM but are hesitant to take that step. Watch for a dose of inspiration from the women leading by example.

📢 Call for Abstracts: 𝟭𝟴𝘁𝗵 𝗜𝗻𝘁𝗲𝗿𝗻𝗮𝘁𝗶𝗼𝗻𝗮𝗹 𝗪𝗼𝗿𝗸𝘀𝗵𝗼𝗽 𝗼𝗻 #PediatricsHIV 𝟮𝟬𝟮𝟲! Submission deadline: 17 April 2026. Join fellow researchers and clinicians to advance #HIV prevention and treatment for infants, children and adolescents. 🔗 Learn more and submit your abstract: lnkd.in/d43EaECG

Big news from the PIPELINE team! We’ve officially recruited our first participant into the PIPELINE RSV-International trial. This milestone marks the start of an important chapter bringing us closer to providing better protection against RSV in infants. More 👉 bit.ly/3O3qsdP

⏰ Last chance to submit your abstract for the 3rd Conference on Innovations in Tuberculosis - highlighting TB research and innovation in African contexts, where the burden is greatest but voices are too often underrepresented. Info & submit abstract ➡️ bit.ly/4tmOp00 @academicmededu.bsky.social

The #ENABLE kick-off meeting is underway in South Africa! @globalhealthedctp3.bsky.social Penta will coordinate Ethics & Regulatory work for a trial testing 2 #bNAbs as intensification therapy alongside oral #ART in high-risk infants with #HIV 👶🏽 Excited to be part of this impactful project 🥰

Did you know that low-risk children often receive the same antibiotic treatment as high-risk patients? This is because we lack clear data on when to safely stop care PediSEP-1 aims to change that and provide the missing data, inform policy change and protect children from #AMR!

PIPELINE RSV International has officially opened its first site! Can we better protect babies and pregnant people from #RSV? PIPELINE RSV hopes to answer this. Swipe to learn more! Read the full announcement here 👉 bit.ly/45mhtdH

📈 New NeoSep1 results! Part 1 shows that fosfomycin and flomoxef are safe and well-tolerated in babies with sepsis. Part 2, designed by our experts, compares antibiotic combinations for treating neonatal sepsis. @pentafoundation.bsky.social @gardp.bsky.social Read more about it 👇

📣 Healthcare professionals: level up your expertise in #HIV & congenital infections 🇮🇹! 🎓 PentaTr@ining course (hybrid): online modules + expert webinars + in-person workshop in Padova, Italy 🗓 Online Apr–Jul 2026 | Residential Sept 2026 🔗 Register now 👉 penta-id.org/hiv-other-co...

Good news for newborn health 👶 New findings from GARDP's #NeoSep1 trial show that off-patent antibiotics, fosfomycin & flomoxef, are safe in newborns with sepsis, supporting affordable treatment options where #AMR burden is highest 🔗 bit.ly/45oK3v1 @pentafoundation.bsky.social @mrcctu.bsky.social

Every year, sepsis claims hundreds of thousands of newborn lives, but new evidence offers hope. 👶 #NeoSep1 Part 1 shows off-patent antibiotics fosfomycin and flomoxef are safe and well tolerated in newborns with suspected #sepsis, including high-risk preterm infants. 💜 👇

On #WorldAIDSDay2025, we recognise the extraordinary efforts of the people who turn evidence into impact, researchers, clinicians and community leaders across the globe. ⬇️

Old drugs, new hope. Instead of waiting decades for new antibiotics, #NeoSep1 is rethinking the ones we already have to treat newborn sepsis more safely and effectively. 🩷 In Africa, the trial is a key pillar of #SNIPAFRICA, funded by EDCTP3 and led by Penta. 🔗 snip-africa.org 📰 Guardian feature 👇

One tablet could change everything. The UNIVERSAL 1 trial is confirming the right dose for a single, dispersible DTG/FTC/TAF pill for children with #HIV, a formulation prioritised by GAP-f. Watch for more #BetterMeds4Kids #WorldChildrensDay #PaediatricHIV #EDCTP

Strengthening paediatric #HIV care in Mozambique: #THRIVE and the Ministry of Health hosted a workshop to improve care for children with advanced HIV disease🌍 @pentafoundation.bsky.social @unitaid.bsky.social 🔗 thriveinfo.org/post/strengthening-paediatric-hiv-care-thrive-ahd-training-in-mozambique

On #WorldPneumoniaDay, we share hope for the children battling severe pneumonia. The PediCAP-A trial showed that it's safe to switch children from IV to oral antibiotics sooner! ✅ Children go home sooner ✅ No more unnecessary IVs & long stays #PediCAP #ChildHealth #Pneumonia #GlobalHealth

Incredible nominations are already coming in for #BFA2025 & we can’t wait to celebrate more champions. Our past Penta BFA winners prove that local heroes can change global health. Entries close 15 November. Nominate your hero today! www.penta-id.org/bfa

📢 3 weeks to go until the Long COVID Conference 2025! Join us in Boston or online for powerful insights from keynote speakers & expert panelists. 🔗 Final call to register: amededu.co/47cQW3M Let’s shape the future of Long COVID care together. #LongCOVIDIntl @academicmededu.bsky.social

Both premature & term newborns in European NICUs are at risk of carrying antibiotic-resistance genes, a key finding from the #NeoIPC feasibility study presented at #jENS2025. The presenter Chiara Minotti earned 1st prize in the Early Career Investigator session! 👏 View presentation: lnkd.in/dTHrFBnn

🌍 Nominate a grassroots health hero for the 2025 Penta Brighter Future Award. 🏆 €5,000 • ✈️ Italy 2026 • 🤝 Global stage 🗓️ Deadline: 15 Nov → penta-id.org/bfa #BrighterFutureAward #GlobalHealth

My name is Jennifer Furin, a Brighter Future Award winner from the United States. There’s no better time to nominate a health hero in your community for this global award. Nominations close 31 October. Nominate now: penta-id.org/bfa #BrighterFutureAward

Meet Jose Sumban, the force ensuring the SUPPORT project research is high-quality and reliable! He coordinates crucial lab efforts against multidrug-resistant infections in children living with HIV & drives key South-to-South collaborations. Learn more: www.supportproject.eu

Can earlier & more frequent follow-ups after hospital discharge save the lives of children with #HIV? SUPPORT fellow Madania Amorim is exploring this vital question. Her research aims to improve outcomes via enhanced follow-up. Learn more: www.supportproject.eu @globalhealthedctp3.bsky.social

🥳 Recruitment complete! The THAI-CARES RSV Study enrolled 120 children in just 9 weeks, a major milestone for this Penta-sponsored trial across 8 sites in Thailand. The Phase II study tests remdesivir in children aged 0-2 with RSV-related infections. 👏 Huge thanks to all site teams! bit.ly/42OubQT

How do we ensure ethical integrity in paediatric clinical trials? Join the #SNIP-AFRICA webinar to explore best practices in ethics, consent, oversight & compliance in research involving children. 🗓️ 25 Sept 2025 🕑 14:00 CEST / 12:00 GMT 🔗 Learn more and register: bit.ly/428FZgG

The final #VERDI project General Assembly has started! Over the next two days, we’ll share results and discuss how four years of VERDI research can drive #preparedness for new pathogens and inform evidence-based policies that prioritise children and pregnant people. ➡️ verdiproject.org

🚨 Happening TODAY! Our Global Aperitivo goes live at 18:00 CEST. 🌍 Scientists from Guinea-Bissau, Argentina, the Philippines & the USA share insights on maternal, child & adolescent health. 💡 How is science taking action at the grassroots? 👉 Join the conversation: ow.ly/vlUF50WYzrs

Do you know someone making a real difference for mothers, children, or young people? 🌍 Nominate them for the Penta Brighter Future Award! 🏆 Winners will receive: A €5,000 award A trip to Italy in May 2026 A place alongside leading scientists & changemakers Nominate them today: penta-id.org/bfa

Meet Cheelo Mwiinga, a SUPPORT fellow. Her work focuses on how prolonged respiratory infections affect the survival of children with HIV after a hospital stay. Did you know children with HIV can carry viruses like RSV for longer? Understanding this could be a game-changer! www.supportproject.eu

Why do many children with #HIV die soon after leaving the hospital? The SUPPORT project is on a mission to find answers and save young lives. Meet the driven SUPPORT fellows working to tackle this urgent challenge. Follow their journey and impact in the weeks ahead! supportproject.eu

We’re excited to announce two opportunities to support our mission of empowering young voices in science and health communication! Check out our website for details ➡️ penta-id.org/work-with-us... #YouthEngagement #HealthCommunication #PentaYoungReporters

The #NeoSep1 trial is underway to find safer, better antibiotic treatments for newborn sepsis 🩷 Active at 2 sites in South Africa w/ 19 babies enrolled, the trial is part of #SNIPAFRICA, a Penta-led African-European collaboration to improve treatment of severe newborn infections 👉 snip-africa.org

The global search is on! Nominations open Sept 15 for the 2nd Penta Brighter Future Award. Six grassroots leaders fighting infectious diseases in maternal, child & adolescent health will be celebrated and given a global platform. Know a hero? Nominate them at penta-id.org/BFA!

📢 10 days left! Submit your abstract for #LongCOVIDIntl 2025 and share your research or insights with a global audience. 🌍 🗓️ Deadline: 29 August 2025, 23:59 EDT 🔗 To submit: amededu.co/41e5mgx More about the Conference 👉 lnkd.in/eDsDP7T6 ‪ @academicmededu.bsky.social

It’s #InternationalYouthDay! Aged 18-25 and ready to use your voice to amplify #HIV research findings to your peers? Join the Penta Young Reporters project and turn science into information that matters to young people globally. Apply by Sept 8 2025! Details here👉 penta-id.org/work-with-us...

📊 Just 55% of health workers know the term Advanced HIV Disease (#AHD), a concern given its impact. A Penta-led #THRIVE assessment found major training gaps in AHD care for children/adolescents. Targeted training is now in the works to improve care for this group. penta-id.org/news/bridgin...

Join us at the next #PentaAperitivo for fresh insights from #IAS2025! If you work in HIV, interested in long-acting injectables, or infectious diseases, don't miss: 𝗧𝗿𝗮𝗻𝘀𝗳𝗼𝗿𝗺𝗶𝗻𝗴 𝗛𝗜𝗩 𝗰𝗮𝗿𝗲 𝗶𝗻 𝗔𝗳𝗿𝗶𝗰𝗮: insights from the IMPALA & BREATHER Plus trials. 🗓️ July 31, 6-7PM Register 👉 bit.ly/451WviW

Penta believes in equitable science—finding better ways to prevent, diagnose, and treat diseases in pregnancy, infancy, childhood, and adolescence. Giving every child a fair chance to thrive. Subscribe to our newsletter ➡️ penta-id.org/penta-newsle... #TheTrio #LilaSamaNina

How effective and safe is dolutegravir for infants and children under 12 years starting treatment in Europe and Thailand? 🤔 Check out findings shared at #PediatricsHIV2025 by the EPPICC study team to find out! 👉 penta-id.org/wp-content/u...